<table-wrap xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th>Reagent type <break/>(species) or <break/>resource</th><th>Designation</th><th>Source or <break/>reference</th><th>Identifiers</th><th>Additional <break/>information</th></tr></thead><tbody><tr><td>Strain, strain background <break/>(<italic>Mus musculus)</italic></td><td>C57BL/6J</td><td>The Jackson Laboratory</td><td>000664</td><td/></tr><tr><td>Strain, strain background <break/>(<italic>Mus musculus)</italic></td><td>Igh<sup>tm1.1(b12)Nemz</sup></td><td>(<xref ref-type="bibr" rid="bib35">Ota et al., 2013</xref>)</td><td>Available in&#160;The Jackson Laboratory <break/>23065</td><td>A floxed neomycin resistance cassette replaced the DQ52-JH cluster in the Igh locus with HIV antibody b12 variable region coding sequence. Cre-mediated recombination removed the neomycin resistance cassette.</td></tr><tr><td>Strain, strain background <break/>(<italic>Mus musculus)</italic></td><td><italic>Igk<sup>tm1.1(b12)Nemz</sup></italic></td><td>(<xref ref-type="bibr" rid="bib35">Ota et al., 2013</xref>)</td><td>Available in&#160;The Jackson Laboratory <break/>23065</td><td>A floxed neomycin resistance cassette replace the J cluster in the Igk locus with the HIV antibody b12 L chain VJ element. Cre-mediated recombination removed the neomycin resistance cassette.</td></tr><tr><td>Strain, strain background <break/>(<italic>Mus musculus)</italic></td><td>B6.129P2(Cg)-Cx3cr1<sup>tm1Litt</sup>/J</td><td>The Jackson Laboratory</td><td>23065</td><td>CX<sub>3</sub>CR1-GFP mice</td></tr><tr><td>Strain, strain background <break/>(<italic>Mus musculus)</italic></td><td>M<italic>fg-e8<sup>-/-</sup></italic> (MFG-E8 KO)</td><td>(<xref ref-type="bibr" rid="bib33">Neutzner et al., 2007</xref>)</td><td/><td>Milk Fat Globule-EGF <break/>Factor 8 (MFG-e8) deficient mice</td></tr><tr><td>Transfected construct <break/>(<italic>Human immunodeficiency virus type 1</italic>)</td><td>pCMV NL4-3 <break/>Gag-eGFP</td><td>(<xref ref-type="bibr" rid="bib16">Guzzo et al., 2017</xref>)</td><td>Dr. Walter Mothes (Yale University)</td><td>Plasmid for <break/>NL4.3-GFP VLPs</td></tr><tr><td>Transfected construct <break/>(<italic>Human immunodeficiency virus type 1</italic>)</td><td>pCMV NL4-3 Gag-mCherry</td><td>This paper <break/>(Materials and methods section)</td><td>Dr. John Kehrl (NIAID/NIH)</td><td>Plasmid for <break/>NL4.3-mCherry VLPs</td></tr><tr><td>Transfected construct <break/>(<italic>Human immunodeficiency virus type 1</italic>)</td><td>HIV-1 NL4-3 Gag-iGFP &#916;Env</td><td>NIH AIDS Reagent Program</td><td>12455</td><td>Plasmid for <break/>delta-Env NL4.3-GFP VLPs</td></tr><tr><td>Transfected construct <break/>(<italic>Friend murine leukemia virus</italic>)</td><td>pSV-A-MLV-env</td><td>NIH AIDS Reagent <break/>Program</td><td>1065</td><td>Plasmid for <break/>MLV VLPs</td></tr><tr><td>Transfected construct <break/>(<italic>Friend murine leukemia virus</italic>)</td><td>pSV-&#936;-MLV-env<sup>-</sup></td><td>NIH AIDS Reagent Program</td><td>3422</td><td>Plasmid for <break/>MLV VLPs</td></tr><tr><td>Transfected construct <break/>(<italic>Friend murine</italic> <break/><italic>leukemia virus</italic>)</td><td>MLV Gag-RFP</td><td>Addgene</td><td>1814</td><td>Plasmid for MLV VLPs</td></tr><tr><td>Chemical compound, drug</td><td>1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC)</td><td>Avanti Polar Lipids</td><td>850375</td><td/></tr><tr><td>Chemical <break/>compound, <break/>drug</td><td>1-oleoyl-2-{6-((7-nitro-2&#8211;1,3-benzoxadiazol-4-yl)amino)hexanoyl}-sn-glycero-3-phosphocholine (NBD-PC)</td><td>Avanti Polar Lipids</td><td>810132</td><td/></tr><tr><td>Chemical compound, <break/>drug</td><td>1,2-dioleoyl-sn-glycero-3-phospho-L-serine (DOPS)</td><td>Avanti Polar Lipids</td><td>840035</td><td/></tr><tr><td>Chemical <break/>compound, <break/>drug</td><td>4-Hydroxy-3-nitrophenylacetyl <break/>hapten-Phycoerythrin (NP-PE)</td><td>Biosearch <break/>Technologies</td><td>N-5070&#8211;1</td><td/></tr><tr><td>Chemical compound, drug</td><td>Pertussis toxin (PTX)</td><td>Millipore <break/>Sigma</td><td>70323-44-3</td><td/></tr><tr><td>Antibody</td><td>&#945;v blocking antibody (&#945;CD51) (RMV-7), (Rat monoclonal)</td><td>BioLegend</td><td>104108</td><td>in vivo blocking (10 &#181;g)</td></tr><tr><td>Antibody</td><td>Mouse MFG-E8 Antibody <break/>(Clone# 340614), <break/>(Rat monoclonal)</td><td>R and D <break/>Systems</td><td>MAB2805</td><td>Dilution factor for FACS (1:500), Section (1:1000)</td></tr><tr><td>Antibody</td><td>Human MFG-E8 Antibody (Clone# 278918), <break/>(Mouse monoclonal)</td><td>R and D Systems</td><td>MAB27671</td><td>Dilution factor <break/>for FACS (1:500)</td></tr><tr><td>Antibody</td><td>Anti-Mouse Follicular <break/>Dendritic Cell (FDC-M1), <break/>(Rat monoclonal)</td><td>BD Biosciences</td><td>551320</td><td>Dilution factor for section (1:1000)</td></tr><tr><td>Antibody</td><td>anti-human &#945;v&#946;3 <break/>integrin (23C6), <break/>(Mouse monoclonal)</td><td>BioLegend</td><td>304413</td><td>Dilution factor for FACS (1:500)</td></tr><tr><td>Antibody</td><td>anti-mouse CD21/35 (7E9), <break/>(Rat monoclonal)</td><td>BioLegend</td><td>123421, 123411, 123409</td><td>BV421, PE, APC, <break/>Dilution factor <break/>for section (1:1000)</td></tr><tr><td>Antibody</td><td>anti-mouse CD35 (8C12), <break/>(Rat monoclonal)</td><td>BD Biosciences</td><td>740029</td><td>Dilution factor <break/>for section (1:1000)</td></tr><tr><td>Antibody</td><td>anti-mouse <break/>CD169 (3D6.112), <break/>(Rat monoclonal)</td><td>BioLegend</td><td>142403</td><td>Dilution factor for <break/>FACS (1:600), Section (1:1500)</td></tr><tr><td>Antibody</td><td>Anti-HIV-1 gp120 <break/>Monoclonal (VRC01), <break/>(Human monoclonal)</td><td>NIH AIDS Reagent <break/>Program</td><td>12033</td><td>Dilution factor for FACS (1:500)</td></tr><tr><td>Peptide, <break/>recombinant <break/>protein</td><td>Recombinant Mouse <break/>MFG-E8 Protein</td><td>R and D Systems</td><td>P21956</td><td/></tr><tr><td>Peptide, recombinant <break/>protein</td><td>Recombinant Human <break/>MFG-E8 Protein</td><td>R and D <break/>Systems</td><td>Q08431</td><td/></tr><tr><td>Peptide, <break/>recombinant <break/>protein</td><td>Recombinant Human <break/>EDIL-3 Protein</td><td>R and D Systems</td><td>6046-ED-050</td><td/></tr><tr><td>Peptide, <break/>recombinant <break/>protein</td><td>Recombinant Human <break/>Integrin alpha V <break/>beta 3 Protein</td><td>R and D Systems</td><td>2308-VN</td><td/></tr><tr><td>Peptide, recombinant <break/>protein</td><td>Cyclo(-RGDyK)</td><td>AnaSpec</td><td>AS-61183&#8211;5</td><td/></tr><tr><td>Commercial assay or kit</td><td>TransIT-293 <break/>Transfection <break/>Reagent</td><td>Mirus <break/>Bio LLC</td><td>MIR 2704</td><td/></tr><tr><td>Software, <break/>algorithm</td><td>Imaris software v.9.0.1 64x</td><td>Oxford Instruments plc</td><td><ext-link ext-link-type="uri" xlink:href="https://imaris.oxinst.com/">https://imaris.oxinst.com/</ext-link></td><td/></tr><tr><td>Software, <break/>algorithm</td><td>LSA AF <break/>Lite software</td><td>Leica Microsystem</td><td><ext-link ext-link-type="uri" xlink:href="https://www.leica-microsystems.com/">https://www.leica-microsystems.com/</ext-link></td><td/></tr><tr><td>Software, <break/>algorithm</td><td>FlowJo</td><td>BD Biosciences</td><td><ext-link ext-link-type="uri" xlink:href="https://www.flowjo.com/solutions/flowjo">https://www.flowjo.com/solutions/flowjo</ext-link></td><td/></tr><tr><td>Software, <break/>algorithm</td><td>Prism software</td><td>GraphPad Software</td><td><ext-link ext-link-type="uri" xlink:href="https://graphpad.com">https://graphpad.com</ext-link></td><td/></tr></tbody></table></table-wrap>